Search

🚀 FIRST US STAKED INJ ETF LISTS ON NASDAQ Canary Capital's Canary Staked INJ ETF (ticker: INJC) began trading on Nasdaq on November 5 — the first US-listed ETF holding Injective's INJ, with staking built in. INJ jumped more than 10% intraday on the debut. The fund stakes at least 90% of its INJ holdings, with net staking rewards reflected in its NAV. Day-one trading was light — just 2,933 shares — with a ~$15M NAV backed by about 1.91M INJ tokens. Another altcoin just got its Wall Street doorway. 🏦 #Injective #INJ #ETF #CryptoETF #Nasdaq #CryptoNews #Staking #Zimbuck

BREAKING: Nasdaq has approved the listing of Canary Capital's Staked INJ ETF — the first US-listed staked product for Injective. The fund will trade under ticker INJC and stake at least 90% of its INJ holdings, with a 1.10% sponsor fee. INJ surged around 10% in 24 hours to near $8.40, leading the CoinDesk 100 gainers. Trading still awaits the S-1 going effective with the SEC. #Injective #INJ #ETF #CryptoNews #Nasdaq #Staking #DeFi #Bitcoin #Ethereum #Zimbuck

🚨 Nasdaq has approved the listing of Canary Capital's Staked INJ ETF — the first-ever staked Injective ETF in the US. It will trade under the ticker INJC. Injective (INJ) jumped around 8.5% to about $8.26 on the news, up roughly 22% from its November 3 low of $6.82. The fund plans to stake at least 90% of its INJ holdings, with a 1.10% annual sponsor fee and BitGo as custodian. Trading can't begin until the S-1 registration statement becomes effective with the SEC. #Injective #INJ #ETF #Nasdaq #Crypto #CryptoNews #DeFi #Zimbuck